(a) Establishment.--The Pharmaceutical Assistance Advisory Board is continued to ensure that the program is providing and continues to provide the assistance intended in a fiscally responsible manner without excessively hampering the pharmaceutical industry.(b) Composition.--The board shall be comprised of the following persons: (1) The Secretary of Aging, who shall serve as its chairman.(2) The Secretary of Revenue.(3) The Secretary of Health.(4) Nine public members appointed as follows:(i) Four practicing Pennsylvania pharmacists whose names are jointly submitted by the Pennsylvania Pharmacists Association and the Pennsylvania Association of Chain Drug Stores and then appointed by the following:(A) One member appointed by the President pro tempore of the Senate.(B) One member appointed by the Minority Leader of the Senate.(C) One member appointed by the Speaker of the House of Representatives.(D) One member appointed by the Minority Leader of the House of Representatives.(ii) Five individuals appointed by the Governor that include the following:(A) One representative from the pharmaceutical industry.(B) Four senior citizens who have not been a part of the pharmaceutical industry, two of whom may be senior advocates.(5) Should a board vacancy not be filled by the appointing authority within 60 days, the power to appoint an individual to the vacancy shall be given to the Secretary of Aging.(c)Review.--Using the annual report submitted by the department pursuant to section 2102 and other appropriate data sources, the board shall conduct an annual review. The board shall develop recommendations concerning any changes in the level of copayment OR deductible . The board shall review the department's therapeutic drug utilization review program on an ongoing basis. The board may also recommend other changes in the structure of the program and direct the department to enter into discussions with the private contractor concerning amendments to the contract, or the department may enter into such discussion if it deems necessary. The copayment or deductible schedule shall only be adjusted on an annual basis.(c.1)Powers and duties.--The board shall advise on the following:(1) The development and implementation of medication synchronization and medication therapy management programs and reimbursement methodologies.(2) Adjustment of the dispensing fee, as needed.(3) Cost-of-living adjustment increases for medication synchronization, medication therapy management and the dispensing fee.(4) The development and modernization of the program, as necessary, to ensure that the program is providing and continues to provide the assistance intended in a fiscally responsible manner. (d)Meetings.--The board shall meet at least two times per year and not more than four times per year.Amended by P.L. TBD 2021 No. 94, § 2, eff. 2/20/2022.Amended by P.L. TBD 2018 No. 87, § 3, eff. 10/23/2018.1971, Aug. 26, P.L. 351, No. 91, § 520, added 1996, Nov. 21, P.L. 741, No. 134, § 2, imd. effective. Amended 2003, Nov. 26, P.L. 212, No. 37, § 4, imd. effective.